13F Data
13F filer · CIK 1306923

Palo Alto Investors LP

PALO ALTO, CA · filing since Q2 2013 · last filing Aug 19, 2026
Reported value
$723.7M
+$69.9M vs prior
Positions
52
New / sold out
3 / 2
Added / reduced
5 / 15
Turnover
4.8%
buys $33.0M · sells $38.3M
Top-10 weight
61.3%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewFIRST TRACKS BIOTHERAPEUTICS+603,489–+$12.1M
AddedCOMPASS THERAPEUTICS INC+4,317,309+285.1%+$9.5M
AddedCELLDEX THERAPEUTICS INC+103,448+34.9%+$3.8M
AddedMIRUM PHARMACEUTICALS INC+23,633+7.3%+$2.8M
NewSAGIMET BIOSCIENCES INC-A+250,000–+$1.9M
NewNEWAMSTERDAM PHARMA CO NV+44,359–+$1.5M
AddedDISC MEDICINE INC+14,927+3.7%+$1.1M
AddedVERASTEM INC+63,592+25.8%+$242.9K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outAMICUS THERAPEUTICS INC-1,113,045-100.0%$-16.1M
Sold outDENALI THERAPEUTICS INC-234,582-100.0%$-4.5M
ReducedIOVANCE BIOTHERAPEUTICS INC-1,053,354-16.6%$-4.4M
ReducedTRAVERE THERAPEUTICS INC-62,928-27.3%$-3.6M
ReducedORUKA THERAPEUTICS INC - Restricted-26,439-44.1%$-2.5M
ReducedANAPTYSBIO INC-34,672-5.4%$-2.3M
ReducedALIGN TECHNOLOGY INC-10,131-24.4%$-1.7M
ReducedNUVATION BIO INC-182,237-35.8%$-1.0M
ReducedPROTHENA CORP PLC-65,413-5.4%$-640.4K
ReducedPYXIS ONCOLOGY INC-146,233-14.5%$-440.2K
7 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $847.3MQ3 2013: $954.1MQ4 2013: $1.1BQ1 2014: $2.4BQ2 2014: $1.3BQ3 2014: $1.3BQ4 2014: $1.7BQ1 2015: $2.0BQ2 2015: $2.2BQ3 2015: $2.1BQ4 2015: $1.8BQ1 2016: $1.3BQ2 2016: $1.3BQ3 2016: $1.7BQ4 2016: $1.8BQ1 2017: $2.1BQ2 2017: $2.1BQ3 2017: $2.4BQ4 2017: $2.3BQ1 2018: $2.3BQ2 2018: $2.5BQ3 2018: $2.5BQ4 2018: $1.9BQ1 2019: $2.4BQ2 2019: $2.1BQ3 2019: $1.5BQ4 2019: $1.8BQ1 2020: $1.2BQ2 2020: $1.7BQ3 2020: $1.8BQ4 2020: $1.9BQ1 2021: $1.8BQ2 2021: $1.8BQ3 2021: $1.7BQ4 2021: $1.6BQ1 2022: $1.3BQ2 2022: $1.1BQ3 2022: $1.3BQ4 2022: $1.2BQ1 2023: $1.2BQ2 2023: $1.2BQ3 2023: $1.1BQ4 2023: $1.1BQ1 2024: $886.7MQ2 2024: $818.7MQ3 2024: $769.9MQ4 2024: $645.4MQ1 2025: $525.1MQ2 2025: $470.0MQ3 2025: $540.4MQ4 2025: $718.4MQ1 2026: $653.9MQ2 2026: $723.7M
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1PTC THERAPEUTICS INCCOM918,846$75.0M10.36%
2ACADIA PHARMACEUTICALS INCCOM2,864,096$72.5M10.01%
3INSMED INCCOM PAR $.01413,980$44.1M6.10%
4MIRUM PHARMACEUTICALS INCCOM348,808$40.8M5.64%
5ANAPTYSBIO INCCOM603,489$40.7M5.63%
6BIOMARIN PHARMACEUTICAL INCCOM682,777$39.1M5.40%
7DYNE THERAPEUTICS INCCOM1,647,521$36.6M5.06%
8UNITED THERAPEUTICS CORPCOM62,587$33.9M4.69%
9DISC MEDICINE INCCOM416,646$30.5M4.21%
10BIOGEN INCCOM140,279$30.3M4.19%
42 more rows. Subscribe for $29/month to see every row, download the data and use the API.